With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|In-UTR mutations in neuroblastoma: Functional consequences and therapeutic implications||Children's Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD||Innovation Grants||2012||Pennsylvania|
|Development of Targeted Therapies in High Risk Childhood Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Sarah Tasian||Young Investigator Grants||2012||Pennsylvania|
|Targeting Neovascularization in Graft-Versus-Host Disease||Memorial Sloan-Kettering Cancer Center / Marcel van den Brink, MD/PhD||Innovation Grants||2012||New York|
|A Role for Notch in Self-renewal in Embryonal Rhabdomyosarcoma||Massachusetts General Hospital / Myron Ignatius, PhD||'A' Award Grants||2012||Massachusetts|
|Improving Thymus Function by RB Inactivation||Lucile Packard Children's Hospital at Stanford University School of Medicine / Julien Sage, PhD||Springboard Grants||2012||California|
|Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database||Huntsman Cancer Institute / Joshua Schiffman, MD||Epidemiology Grants||2012||Utah|
|Identification of predisposition genes for Ewing sarcoma segregating in high-risk pedigrees||Huntsman Cancer Institute / Lisa Cannon-Albright, PhD||Innovation Grants||2012||Utah|
|Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia||Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD||Young Investigator Grants||2012||Washington|
|Exploiting WT1 Genomic Alterations for Target Identification and MRD Monitoring in Pediatric AML||Fred Hutchinson Cancer Research Center / Phoenix Ho||Young Investigator Grants||2012||Washington|
|Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML||Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD||'A' Award Grants||2012||Washington|